Table 5 Odds ratio of having indication for treatment (full model)
Antipsychotics | Proton pump inhibitors | Digoxin | Loop diuretics | Serotonin reuptake inhibitors | |
|---|---|---|---|---|---|
OR (CI 95 %) | OR (CI 95 %) | OR (CI 95 %) | OR (CI 95 %) | OR (CI 95 %) | |
Gender | |||||
Male | 1 | 1 | 1 | 1 | 1 |
Female | 0.78 (0.62-0.98) | 0.99 (0.89-1.11) | 1.19 (0.98-1.45) | 1.04 (0.97-1.12) | 0.83 (0.75-0.91) |
Age | |||||
65-79 | 1 | 1 | 1 | 1 | 1 |
80+ | 0.66 (0.54-0.82) | 0.82 (0.74-0.92) | 0.85 (0.70-1.03) | 0.97 (0.90-1.04) | 0.61 (0.56-0.67) |
Multi-morbidity level | |||||
RUBa 3 (low) | 3.18 (1.90-5.32) | 2.86 (2.07-3.96) | 7.16 (5.31-9.67) | 4.09 (3.60-4.65) | 3.00 (2.47-3.65) |
RUB 4 | 3.93 (2.29-6.75) | 2.49 (1.76-3.52) | 15.7 (10.8-22.8) | 7.11 (6.11-8.26) | 3.42 (2.76-4.23) |
RUB 5 (high) | 3.07 (1.69-5.56) | 2.99 (2.07-4.31) | 26.4 (15.4-45.4) | 10.5 (8.63-12.8) | 3.58 (2.81-4.55) |
Income level | |||||
1 (low) | 1 | 1 | 1 | 1 | 1 |
2 | 1.56 (1.20-2.02) | 1.04 (0.90-1.19) | 0.84 (0.66-1.06) | 0.93 (0.85-1.02) | 1.08 (0.97-1.21) |
3 | 2.10 (1.57-2.80) | 1.02 (0.88-1.18) | 0.87 (0.67-1.12) | 1.00 (0.91-1.11) | 1.17 (1.04-1.33) |
4 (high) | 1.51 (1.06-2.13) | 0.99 (0.84-1.16) | 1.00 (0.74-1.34) | 1.00 (0.89-1.12) | 1.12 (0.98-1.29) |